MX7663E - Un procedimiento para preparar un derivado de una enzima fibrinolitica - Google Patents

Un procedimiento para preparar un derivado de una enzima fibrinolitica

Info

Publication number
MX7663E
MX7663E MX8411401U MX1140184U MX7663E MX 7663 E MX7663 E MX 7663E MX 8411401 U MX8411401 U MX 8411401U MX 1140184 U MX1140184 U MX 1140184U MX 7663 E MX7663 E MX 7663E
Authority
MX
Mexico
Prior art keywords
derivative
preparing
procedure
fibrinolytic enzyme
fibrinolytic
Prior art date
Application number
MX8411401U
Other languages
English (en)
Inventor
Richard Anthony Godwin Smith
Original Assignee
Beecham Group Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beecham Group Plc filed Critical Beecham Group Plc
Publication of MX7663E publication Critical patent/MX7663E/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62Oxygen or sulfur atoms
    • C07D213/70Sulfur atoms
    • C07D213/71Sulfur atoms to which a second hetero atom is attached
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N11/00Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
    • C12N11/02Enzymes or microbial cells immobilised on or in an organic carrier
    • C12N11/06Enzymes or microbial cells immobilised on or in an organic carrier attached to the carrier via a bridging agent

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Hematology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Pyridine Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
MX8411401U 1983-12-24 1984-12-20 Un procedimiento para preparar un derivado de una enzima fibrinolitica MX7663E (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB838334499A GB8334499D0 (en) 1983-12-24 1983-12-24 Derivatives

Publications (1)

Publication Number Publication Date
MX7663E true MX7663E (es) 1990-06-19

Family

ID=10553871

Family Applications (1)

Application Number Title Priority Date Filing Date
MX8411401U MX7663E (es) 1983-12-24 1984-12-20 Un procedimiento para preparar un derivado de una enzima fibrinolitica

Country Status (12)

Country Link
US (3) US4600580A (es)
EP (2) EP0155388B1 (es)
JP (1) JPH0829085B2 (es)
AU (1) AU580747B2 (es)
CA (1) CA1271718A (es)
DE (2) DE3477469D1 (es)
ES (2) ES8609468A1 (es)
GB (1) GB8334499D0 (es)
GR (1) GR82558B (es)
MX (1) MX7663E (es)
NZ (1) NZ210696A (es)
ZA (1) ZA849927B (es)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5650270A (en) * 1982-02-01 1997-07-22 Northeastern University Molecular analytical release tags and their use in chemical analysis
GB8334498D0 (en) * 1983-12-24 1984-02-01 Beecham Group Plc Compounds
GB8334499D0 (en) * 1983-12-24 1984-02-01 Beecham Group Plc Derivatives
US4880776A (en) * 1983-12-24 1989-11-14 Beecham Group P.L.C. Plasmin A-chain urokinase B-chain hybrid protein
GB8400653D0 (en) * 1984-01-11 1984-02-15 Beecham Group Plc Conjugates
GB8430253D0 (en) * 1984-11-30 1985-01-09 Beecham Group Plc Compounds
US4916070A (en) * 1986-04-14 1990-04-10 The General Hospital Corporation Fibrin-specific antibodies and method of screening for the antibodies
GB8707369D0 (en) * 1987-03-27 1987-04-29 Beecham Group Plc Enzyme derivatives
US5217705A (en) * 1987-09-25 1993-06-08 Neorx Corporation Method of diagnosing blood clots using fibrin-binding proteins
US5151359A (en) * 1988-05-19 1992-09-29 Mitsui Toatsu Chemicals Incorporated Method for producing of human tissue type plasminogen activator
US5811265A (en) * 1988-08-19 1998-09-22 The General Hospital Corporation Hybrid immunoglobulin-thrombolytic enzyme molecules which specifically bind a thrombus, and methods of their production and use
US5609869A (en) * 1988-08-19 1997-03-11 The General Hospital Corporation Hybrid immunoglobulin-thrombolytic enzyme molecules which specifically bind a thrombus, and methods of their production and use
US5183754A (en) * 1988-10-04 1993-02-02 Mitsui Toatsu Chemicals, Incorporated Method for production of human tissue type plasminogen activator
US5272076A (en) * 1991-06-13 1993-12-21 Eli Lilly And Company Compounds and methods for treatment of thromboembolic disorders using an adduct of t-PA
US6608204B1 (en) * 1994-12-13 2003-08-19 Corvas International, Inc. Aromatic heterocyclic derivatives as enzyme inhibitors
JP2001504813A (ja) * 1996-10-21 2001-04-10 クウォドラント、ヘルスケアー、(ユーケー)、リミテッド 代用血小板、及びそれらの製造に適した抱合法
CA2280866A1 (en) * 1997-02-13 1998-08-20 Lxr Biotechnology Inc. Organ preservation solution
WO2004082640A2 (en) * 2003-03-19 2004-09-30 New Century Pharmaceuticals, Inc. Human serum albumin conjugates with therapeutic compounds
US7541159B2 (en) * 2004-04-14 2009-06-02 The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration Molecular-specific urokinase antibodies
US10878790B1 (en) 2020-03-13 2020-12-29 Aspire Precision Instruments, LLC Device and method for amplitude modulated optical pickup for a stringed instrument

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US428593A (en) * 1890-05-27 Sleigh
US4464468A (en) * 1968-03-29 1984-08-07 Agence Nationale De Valorisation De La Recherche (Anvar) Immobilization of active protein by cross-linking to inactive protein
GB1463513A (en) * 1974-08-13 1977-02-02 Beecham Group Ltd Enzymes
CS181417B1 (en) * 1975-03-27 1978-03-31 Miroslav Bleha Method for preparing insoluble biologically active compounds
DE2621974A1 (de) * 1976-05-18 1977-11-24 Max Planck Gesellschaft Verfahren zur herstellung eines zur kovalenten bindung mit biologisch aktivem material befaehigten traegermaterials
US4082612A (en) * 1976-09-24 1978-04-04 Michael Reese Research Foundation Plasminogen activator complex
US4134792A (en) * 1976-12-06 1979-01-16 Miles Laboratories, Inc. Specific binding assay with an enzyme modulator as a labeling substance
SE430062B (sv) * 1977-03-04 1983-10-17 Pharmacia Fine Chemicals Ab Kopplings- eller tioleringsreagens
SE427505B (sv) * 1977-03-04 1983-04-11 Pharmacia Diagnostics Ab Reagens till anvendning vid immunkemiska bestemningsmetoder
US4233401A (en) * 1977-07-14 1980-11-11 Syva Company Antienzyme homogeneous competitive binding assay
EP0000938B1 (en) * 1977-08-22 1984-10-17 National Research Development Corporation Macromolecular covalent conjugates, methods for preparing and pharmaceutical compositions containing them
NZ191320A (en) * 1978-09-07 1982-09-14 Beecham Group Ltd In vivo fibrinolytic enzyme having active site blocked by hydrolytically removable group pharmaceutical compositions
SE446184B (sv) * 1979-01-12 1986-08-18 Toyo Jozo Kk Polyfunktionell disulfidforening anvendbar som tverbindande medel
US4305926A (en) * 1979-09-13 1981-12-15 Johannes Everse Immobilization of Streptokinase
US4286964A (en) * 1979-10-12 1981-09-01 Seed Brian S Polyfunctional epoxides and halohydrins used as bridging groups to bind aromatic amine group-containing alcohols and thiols to hydroxyl bearing substrates
FR2470773B1 (es) * 1979-11-28 1983-01-28 Pasteur Institut
NL8003402A (nl) * 1980-06-11 1982-01-04 Leuven Res & Dev Vzw Nieuwe plasminogeen-activator en farmaceutisch preparaat met trombolytische werking.
SE450834B (sv) * 1980-11-19 1987-08-03 Biocompat Inc Sett att binda ett protein till en berare innehallande hydroxylgrupper
SE8102193L (sv) * 1981-04-06 1982-10-07 Pharmacia Ab Terapeutiskt aktiv organisk forening och dess anvendning
US4429008B1 (en) * 1981-12-10 1995-05-16 Univ California Thiol reactive liposomes
DE3361610D1 (en) * 1982-04-07 1986-02-06 Beecham Group Plc Enzyme derivatives, process for preparing them and pharmaceutical compositions containing them
US4536391A (en) * 1982-11-17 1985-08-20 Otsuka Pharmaceutical Co. Process for preparing urokinase complex
GB8334499D0 (en) * 1983-12-24 1984-02-01 Beecham Group Plc Derivatives
GB8400653D0 (en) * 1984-01-11 1984-02-15 Beecham Group Plc Conjugates
US4542225A (en) * 1984-08-29 1985-09-17 Dana-Farber Cancer Institute, Inc. Acid-cleavable compound

Also Published As

Publication number Publication date
ES8605476A1 (es) 1986-03-16
DE3477469D1 (en) 1989-05-03
JPS60178864A (ja) 1985-09-12
DE3484655D1 (de) 1991-07-04
ES539000A0 (es) 1986-09-01
EP0155388B1 (en) 1989-03-29
GB8334499D0 (en) 1984-02-01
EP0283563A2 (en) 1988-09-28
GR82558B (en) 1985-04-23
EP0155388A2 (en) 1985-09-25
AU580747B2 (en) 1989-02-02
US4741903A (en) 1988-05-03
ES8609468A1 (es) 1986-09-01
EP0283563B1 (en) 1991-05-29
CA1271718A (en) 1990-07-17
NZ210696A (en) 1989-04-26
EP0283563A3 (en) 1988-11-23
ZA849927B (en) 1986-04-30
US4600580A (en) 1986-07-15
EP0155388A3 (en) 1986-12-10
ES546739A0 (es) 1986-03-16
AU3707284A (en) 1985-07-04
JPH0829085B2 (ja) 1996-03-27
US4730050A (en) 1988-03-08

Similar Documents

Publication Publication Date Title
ES483888A0 (es) Un procedimiento para la preparacion de un derivado de una enzima fibrinolitica
MX7663E (es) Un procedimiento para preparar un derivado de una enzima fibrinolitica
ES535210A0 (es) Un procedimiento para producir una enzima de glucoamilasa
ES539563A0 (es) Un procedimiento para preparar derivados de fenilamino-mer- captoimidazol
ES541465A0 (es) Procedimiento para la produccion de una ciclosporina
ES526246A0 (es) Un metodo de produccion de una preparacion en particulas de enzima inmovilizado
ES537828A0 (es) Procedimiento para preparar agentes fibrinoliticos
KR860004897A (ko) 세팔로스포린 유도체의 제조방법
ES526247A0 (es) Un metodo de produccion de una preparacion de enzima inmovilizado
AR240823A1 (es) Procedimiento de preparacion de una cefalosporina
DE3476785D1 (en) Enzyme derivatives
ES541687A0 (es) Procedimiento para preparar cefalosporinas
MX156049A (es) Un procedimiento para la preparacion de una n - piperazinilalcanolanilida
ES552910A0 (es) Un procedimiento para preparar derivados de indol
MX13291A (es) Un derivado de pirrol ortocondensado y procedimiento para su preparacion.
ES543236A0 (es) Un procedimiento para preparar un derivado de dihidropirida-zinona
GR80965B (en) Method for the preparation of protease inhibitors
MX5857E (es) Procedimiento mejorado para la produccion de una enzima de fructosil transferasa
ES546296A0 (es) Un procedimiento para la produccion de una cefalosporina
ES557566A0 (es) Un procedimiento para preparar derivados de azirino-pirrolo-indol-diona
ES544640A0 (es) Un procedimiento para la preparacion de una cefalosporina
ES555459A0 (es) Procedimiento para preparar derivados de saframicina a.
ES557266A0 (es) Un procedimiento para la preparacion de derivados enzimaticos
ES528985A0 (es) Un procedimiento para la preparacion de una b- lactama
RO88722A (ro) Procedeu pentru prepararea unor 22-eteri-hexanorbrasinolid